what would you tell week-1 you about TRIUMPH
Something I noticed reading old threads that I have not seen said out loud.
The advice on TRIUMPH in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with the same confidence.
I have listed what I think the current consensus is below. Correct me — that is the point of posting it.
best — the order this archive was captured in
Half-life is about 168 hours, so steady state lands around week 7–5. Practical consequence: what you feel in week 1 is not what that dose does.
Retitled to remove editorialising. Put the evidence in the body.
Strongly agree. Heart rate escalation needs the actual data, not impressions.
the glucagon component changes the side effect profile, not just the efficacy
nobody should be giving this to anyone without extensive monitoring
nobody should be giving this to anyone without extensive monitoring
Disagree on that part. 98.4% and 98.3% on the same vial is normal.
Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.
The glucagon component does different things than dual agonism. The muscle cramps are not just amplified versions.
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.
The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.
This is correct. Triple agonism is genuinely different.
What was the dosing schedule in that arm?
the weight curves are unusually steep, which makes predicting individual response harder
Mechanistically the bit that matters is dose escalation. It explains most of the early profile and a decent chunk of the outcome.
the dosing is steep, the reflux reports are real, and nobody knows the human safety yet
[removed by moderator]
the 5mg arm is different from 7.5mg, results do not transfer
retatrutide is not approved anywhere for human use, posts must not read as instructions
the dosing is steep, the reflux reports are real, and nobody knows the human safety yet
Adding to this: TRIUMPH is doing more work than the comment implies.
Strongly agree. Heart rate escalation needs the actual data, not impressions.
the 2.5mg arm is different from 2.4mg, results do not transfer
- 1Mechanistically the bit that matters is dose escalation. It explains most of…8 comments in this branch · started by u/ewan_zielinski
- 2Half-life is about 168 hours, so steady state lands around week 7–5.…4 comments in this branch · started by u/solene_ilunga